Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole

The endocrine therapy is the new frontiers of many breast cancers hormone sensitive. Hormone therapy for treating women with hormone receptor-positive cancer suppresses breast cancer growth either by reducing estrogen synthesis or by interfering with the action of estrogen within tumor cells. In thi...

Full description

Bibliographic Details
Main Authors: Vincenzo Monda, Gelsy A. Lupoli, Giovanni Messina, Rosario Peluso, Annalisa Panico, Ines Villano, Monica Salerno, Francesco Sessa, Francesca Marciello, Fiorenzo Moscatelli, Anna Valenzano, Leonardo Molino, Roberta Lupoli, Francesco Fonderico, Anna Tortora, Agata Pisano, Maria Ruberto, Marsala Gabriella, Gina Cavaliere, Giovanna Trinchese, Maria P. Mollica, Luigi Cipolloni, Giuseppe Cibelli, Marcellino Monda, Giovanni Lupoli, Antonietta Messina
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-09-01
Series:Frontiers in Pharmacology
Subjects:
health-related quality of life
bone density
anastrozole
risedronate
breast cancer
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00632/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00632/full

Similar Items